Basic diagnostic algorithm to link the molecular line probe assay with solid culture- and liquid culture-based growth detection and susceptibility testing.

Slides:

Advertisements

Similar presentations

Agenda Background Current testings Xpert MTB/RIF product PAGE | 1.

Advertisements

What Gold Standard for Rifampicin Testing?: the future of molecular testing TAG Meeting, Manila, 9-12 December 2014 Richard Lumb Mycobacterium Reference.

Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.

TB Diagnostics: Update on Policies and Pipeline

Comparison of Molecular and Conventional Methods for Detection of Multidrug-Resistant Tuberculosis in the United States, 2009 to 2011 Mitchell A. Yakrus,

CLINICAL DIAGNOSTIC TB LABORATORY Alexander Sloutsky, Director University of Massachusetts Supranational Reference TB Laboratory Boston, MA.

Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.

Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2011 National Center for HIV/AIDS, Viral Hepatitis, STD, and.

Revision of new diagnostics for TB

TB Methodologies Dr. John G. Magee Regional Reference Centre for Mycobacteriology Health Protection Agency Regional Laboratory, Newcastle upon Tyne.

Molecular diagnosis of drug resistant tuberculosis by a DNA array

Do we need to test for isoniazid resistance? No conflict of interest Claudia Denkinger, MD PhD McGill University, Montreal Foundation for Innovative New.

Patient with Presumptive TB HIV Status PositiveNegative % Empiric Tx of Patients with Active TB % Empiric Tx of TB-Symptomatic Patients without True TB.

MULTIDRUG- RESISTANT TUBERCULOSIS (MDR-TB) by Dr Mat Zuki Mat Jaeb 1.

Bacteriophage based test for the rapid detection & Antibiotic sensitivity test of TB Viro102: Bacteriophages & Phage Therapy 3 Credit hours NUST Centre.

TB – LABORATORY INVESTIGATIONS by Dr. Zubaidah Abdul Wahab Datin Dr. Ganeswrie Raj 1.

Article review Rapid Molecular Detection of Tuberculosis and Rifampin Resistance [MTB-RIF test] Catharina C. Boehme, M.D., Pamela Nabeta, M.D., Doris Hillemann,

Drug Resistant Tuberculosis

CASES OF PLEURAL EFFUSION (n=56)

Control of tuberculosis in Serbia:

TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.

Treatment algorithm for tuberculosis

Figure 1. Trends of positive-to-negative culture conversion assessed by weekly serial induced sputum after adequate standard anti-tuberculosis medication.

World Tuberculosis Day 2014

Treatment algorithm for tuberculosis

1 Drug susceptible TB Limited resistance MDR-TB (Frieden, 1993) XDR-TB

Drug Resistant (DR) TB (Back to Basics)

Laboratory ‘Network’ Update New York State Department of Health

World Tuberculosis Day 2015

Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm S.O. Simons, T. van der Laan,

Tuberculosis situation in the EU/EEA, 2016

World Tuberculosis Day 2014

STREAM (Evaluation of a Standardised Treatment Regimen of Anti-tuberculosis Drugs for Patients with Multidrug-resistant Tuberculosis) treatment regimens.

Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array W.-L. Huang, Z.-J. Hsu, T.C.

Tb: Screening & Diagnosis (1)

Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,

L. Zhang, Q. Meng, S. Chen, M. Zhang, B. Chen, B. Wu, G. Yan, X

Itraconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.

Timeline of development of key elements of the Cambodian MDR-TB treatment programme. *GLC1 application for patients enrolled in the CAMbodian Early vs.

Clinical Epidemiology and Global Health

Usability statistics among top 10 tuberculosis (TB) units by transaction type for key data fields. Usability statistics among top 10 tuberculosis (TB)

Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis C.C. Naidoo, M. Pillay Clinical.

Approximate numbers of cases per 100,000 individuals caused by penicillin resistance for each year (left). Approximate numbers of cases per 100,000 individuals.

Detection of Ebola virus infection in nonfatal versus fatal cases.

Increasing prevalence of multidrug resistance among P

Number of outbreaks associated with drinking water by water system type and year (n = 780), 1971 to “Other” includes outbreaks associated with bottled.

Percentages of outbreak deficiencies (n = 671) in public water systems (n = 656) by time period, 1971 to 2006, excluding outbreaks associated with Legionella.

Examples of antibiotic hybrid drugs that are active against Gram-negative pathogens: trimethoprim linked to ciprofloxacin–BP-4Q-002 (hybrid 5), the TyrRS.

Examples of advanced hybrid antibiotics undergoing clinical trials: cadazolid (hybrid 17) and TNP-2092, also known as CBR-2092 (hybrid 18). Examples of.

Number of outbreaks associated with drinking water by system type and month (n = 762), 1971 to 2006, excluding outbreaks associated with commercially bottled.

Structure of cefiderocol (hybrid 10), previously known as S , derived by linking ceftazidime to the siderophore catechol 2-chloro-3,4-dihydroxybenzoic.

Amoeba culturing methods for recovering amoeba-resisting microorganisms (ARMs). Amoeba culturing methods for recovering amoeba-resisting microorganisms.

Diagnostic tools for intestinal pathogenic E. coli.

Hector H. García et al. Clin. Microbiol. Rev. 2002; doi: /CMR

Publications on biosensors for the field in general compared with the specific detection of whole bacteria. Publications on biosensors for the field in.

Multiplex PCR assay to detect common resistance determinants in B

Diversity of resistant and susceptible isolates.

Figure 4. Clinical course of patients with disseminated MDR-tuberculosis. MTB, Mycobacterium tuberculosis ; B-MRI, brain MRI; B-CT, brain CT; TB, tuberculosis;

Roberta B. Carey et al. Clin. Microbiol. Rev. 2018; doi: /CMR

Schematic representation of 5′→3′ exonuclease cleavage of a 5′-labeled (small black star) probe with a 3′-phosphate (grey circle) extension blocker. Schematic.

Synchronization of a basic diagnostic algorithm (linked diagnostic tests) with different levels of diagnostic services. Synchronization of a basic diagnostic.

The future TB clinic. The future TB clinic. Sputum, saliva, and fecal samples are collected from patients for genome sequencing, SNP typing, or metagenomic.

The Scorpions primer is an extension of molecular beacons.

Fig. 1. Antituberculosis drug resistance rate (%) and pattern in sanatoria of North Korea: (A) patients (n = 489) in all sanatoria analyzed in this study,

Fluconazole zone diameter distributions for all Candida spp

Specimen types, diagnostic tests, and anatomical locations for determining a potential current or recent Legionella infection. Specimen types, diagnostic.

Schematic representation of the relationships between acid resistance (urease activity and urea transport), nitrogen metabolism (ammonia production), metal.

Example of population analysis profile curves for vancomycin-susceptible and heterogeneous vancomycin-intermediate S. aureus strains. Example of population.

Amino acid substitutions in SHV ESBL derivatives.

Presentation transcript:

Basic diagnostic algorithm to link the molecular line probe assay with solid culture- and liquid culture-based growth detection and susceptibility testing. Basic diagnostic algorithm to link the molecular line probe assay with solid culture- and liquid culture-based growth detection and susceptibility testing. AFB, acid-fast bacilli; DST, drug susceptibility testing; EMB, ethambutol; FQ, fluoroquinolones; INH, isoniazid; LPA, line probe assay; MDR, multidrug resistant; MTB, Mycobacterium tuberculosis; MTB DRplus, LPA for M. tuberculosis and resistance to RIF and INH; MTB DRsl, LPA for second-line M. tuberculosis drugs; RIF, rifampin; XDR, extensively drug resistant. Linda M. Parsons et al. Clin. Microbiol. Rev. 2011; doi:10.1128/CMR.00059-10